Renal manifestations in scleroderma: Evidence for subclinical renal disease as a marker of vasculopathy

International Journal of Rheumatology

Volumn 2010, Issue , 2010, Pages

  Shanmugam, Victoria K ^a   Steen, Virginia D ^a  

^a GEORGETOWN UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALBUMIN; BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ILOPROST; INTERCELLULAR ADHESION MOLECULE 1; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; NIFEDIPINE; PENICILLAMINE; PHOSPHOLIPID ANTIBODY; VASCULAR CELL ADHESION MOLECULE 1;

ANTIPHOSPHOLIPID ASSOCIATED NEPHROPATHY; CREATININE BLOOD LEVEL; CRUSH SYNDROME; DIFFUSE SCLERODERMA; DOPPLER ECHOGRAPHY; ENDOTHELIAL DYSFUNCTION; GLOMERULUS FILTRATION RATE; GOODPASTURE SYNDROME; HUMAN; HYPERTENSION; HYPOTENSION; KIDNEY BIOPSY; KIDNEY BLOOD FLOW; KIDNEY DISEASE; KIDNEY DYSFUNCTION; KIDNEY FAILURE; KIDNEY INJURY; KIDNEY PLASMA FLOW; KIDNEY VASCULAR RESISTANCE; LIMITED SCLERODERMA; LUPUS ERYTHEMATOSUS; MYELOPEROXIDASE ANTINEUTROPHIL CYTOPLASMIC ANTIBODY ASSOCIATED GLOMERULONEPHRITIS; NORMOTENSIVE SCLERODERMA RENAL CRISIS; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEIN BLOOD LEVEL; PROTEIN ELECTROPHORESIS; PROTEIN URINE LEVEL; PROTEINURIA; RENAL FUNCTIONAL RESERVE; RENAL SYSTEM PARAMETERS; RENOVASCULAR HYPERTENSION; REVIEW; SCLERODERMA; SCLERODERMA RENAL CRISIS; SYSTEMIC SCLEROSIS; VASCULAR DISEASE;

EID: 79955089288     PISSN: 16879260     EISSN: 16879279     Source Type: Journal    
DOI: 10.1155/2010/538589     Document Type: Review

References (60)

1. Helmick C. G., Felson D. T., Lawrence R. C., Arnold L. M., Choi H., Deyo R. A., Gabriel S., Hirsch R., Hochberg M. C., Hunder G. G., Jordan J. M., Katz J. N., Kremers H. M., Wolfe F., Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I Arthritis and Rheumatism 2008 58 1 15 25
2. Abraham D. J., Krieg T., Distler J., Distler O., Overview of pathogenesis of systemic sclerosis Rheumatology 2009 48 supplement 3 iii3 iii7
3. LeRoy E. C., Black C., Fleischmajer R., Jablonska S., Krieg T., Medsger T. A. Jr., Wollheim F., Scleroderma (systemic sclerosis): classification, subsets and pathogenesis Journal of Rheumatology 1988 15 2 202 205 (Pubitemid 18073738)
4. Steen V. D., The many faces of scleroderma Rheumatic Disease Clinics of North America 2008 34 1 1 15 (Pubitemid 351329460)
5. Giordano M., Valentini G., Migliaresi S., Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis Journal of Rheumatology 1986 13 5 911 916 (Pubitemid 17203925)
6. Ingraham K. M., O'Brien M. S., Shenin M. A.X., Derk C. T., Steen V. D., Gastric antral vascular ectasia in systemic sclerosis: demographics and disease predictors The Journal of Rheumatology 2010 37 3 603 607
7. Steen V. D., Scleroderma renal crisis Rheumatic Disease Clinics of North America 2003 29 2 315 333 (Pubitemid 36765123)
8. Trostle D. C., Bedetti C. D., Steen V. D., Al-Sabbagh M. R., Zee B., Medsger T. A. Jr., Renal vascular histology and morphometry in systemic sclerosis. A case-control autopsy study Arthritis and Rheumatism 1988 31 3 393 400 (Pubitemid 18091662)
9. Cannon P. J., Hassar M., Case D. B., Casarella W. J., Sommers S. C., LeRoy E. C., The relationship of hypertension and renal failure in scleroderma (progressive systemic sclerosis) to structural and functional abnormalities of the renal cortical circulation Medicine 1974 53 1 1 46
10. Anders H. J., Wiebecke B., Haedecke C., Sanden S., Combe C., Schlndorff D., MPO-ANCA-Positive crescentic glomerulonephritis: a distinct entity of scleroderma renal disease? American Journal of Kidney Diseases 1999 33 4, article e3
11. Hillis G. S., Khan I. H., Simpson J. G., Rees A. J., Scleroderma, D-penicillamine treatment, and progressive renal failure associated with positive antimyeloperoxidase antineutrophil cytoplasmic antibodies American Journal of Kidney Diseases 1997 30 2 279 281 (Pubitemid 27330347)
12. Kovalchik M. T., Guggenheim S. J., Silverman M. H., Robertson J., Steigerwald J., The kidney in progressive systemic sclerosis. A prospective study Annals of Internal Medicine 1978 89 6 881 887 (Pubitemid 9050988)
13. Steen V. D., Medsger T. A. Jr., Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis Arthritis and Rheumatism 1998 41 9 1613 1619 (Pubitemid 28459919)
14. Penn H., Howie A. J., Kingdon E. J., Bunn C. C., Stratton R. J., Black C. M., Burns A., Denton C. P., Scleroderma renal crisis: patient characteristics and long-term outcomes QJM 2007 100 8 485 494 (Pubitemid 47241915)
15. Teixeira L., Mouthon L., Mahr A., Berezn A., Agard C., Mehrenberger M., Nol L.-H., Trolliet P., Frances C., Cabane J., Guillevin L., Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients Annals of the Rheumatic Diseases 2008 67 1 110 116
16. Steen V. D., Medsger T. A., Changes in causes of death in systemic sclerosis, 19722002 Annals of the Rheumatic Diseases 2007 66 7 940 944 (Pubitemid 46999798)
17. Helfrich D. J., Banner B., Steen V. D., Medsger T. A. Jr., Normotensive renal failure in systemic sclerosis Arthritis and Rheumatism 1989 32 9 1128 1134 (Pubitemid 19237867)
18. Akoglu H., Atilgan G. K., Ozturk R., Yenigun E. C., Gonul I. I., Odabas A. R., A "silent" course of normotensive scleroderma renal crisis: case report and review of the literature Rheumatology International 2009 29 10 1223 1229
19. Mimura I., Hori Y., Matsukawa T., Uozaki H., Tojo A., Fujita T., Noncrescentic ANCA-associated renal crisis in systemic sclerosis Clinical Nephrology 2008 70 2 183 185
20. Endo H., Hosono T., Kondo H., Antineutrophil cytoplasmic autoantibodies in 6 patients with renal failure and systemic sclerosis Journal of Rheumatology 1994 21 5 864 870 (Pubitemid 24168670)
21. Derk C. T., Jimenez S. A., Goodpasture-like syndrome induced by D-penicillamine in a patient with systemic sclerosis: report and review of the literature The Journal of Rheumatology 2003 30 7 1616 1620 (Pubitemid 36835465)
22. Merkel P. A., Chang Y., Pierangeli S. S., Convery K., Harris E. N., Polisson R. P., The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases American Journal of Medicine 1996 101 6 576 583 (Pubitemid 27150034)
23. Parodi A., Drosera M., Barbieri L., Rebora A., Antiphospholipid antibody system in systemic sclerosis Rheumatology 2001 40 1 111 112 (Pubitemid 32124060)
24. Schoenroth L., Fritzler M., Lonzetti L., Sencal J.-L., Antibodies to 2 glycoprotein I and cardiolipin in SSc Annals of the Rheumatic Diseases 2002 61 2 183a 184a
25. Wielosz E., Dryglewska M., Majdan M., Antiphospholipid antibodies and kidney involvement in patients with systemic sclerosis Clinical Rheumatology 2009 28 8 955 959
26. Kingdon E. J., Knight C. J., Dustan K., Irwin A. G., Thomas M., Powis S. H., Burns A., Hilson A. J. W., Black C. M., Calculated glomerular filtration rate is a useful screening tool to identify scleroderma patients with renal impairment Rheumatology 2003 42 1 26 33 (Pubitemid 36131563)
27. Scheja A., Bartosik I., Wuttge D. M., Hesselstrand R., Renal function is mostly preserved in patients with systemic sclerosis Scandinavian Journal of Rheumatology 2009 38 4 295 298
28. Steen V. D., Syzd A., Johnson J. P., Greenberg A., Medsger T. A. Jr., Kidney disease other than renal crisis in patients with diffuse scleroderma Journal of Rheumatology 2005 32 4 649 655 (Pubitemid 40524696)
29. Mohamed R. H., Zayed H. S., Amin A., Renal disease in systemic sclerosis with normal serum creatinine Clinical Rheumatology 2010 29 7 729 737
30. Campo A., Mathai S. C., Le Pavec J., Zaiman A. L., Hummers L. K., Boyce D., Hemodynamic predictors of survival in scleroderma-related pulmonary arterial hypertension American Journal of Respiratory and Critical Care Medicine 2010 182 2 252 260
31. Livi R., Teghini L., Pignone A., Generini S., Matucci-Cerinic M., Cagnoni M., Renal functional reserve is impaired in patients with systemic sclerosis without clinical signs of kidney involvement Annals of the Rheumatic Diseases 2002 61 8 682 686 (Pubitemid 34787704)
32. Anavekar N. S., McMurray J. J.V., Velazquez E. J., Solomon S. D., Kober L., Rouleau J.-L., White H. D., Nordlander R., Maggioni A., Dickstein K., Zelenkofske S., Leimberger J. D., Califf R. M., Pfeffer M. A., Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction The New England Journal of Medicine 2004 351 13 1285 1295 (Pubitemid 39258422)
33. Go A. S., Chertow G. M., Fan D., McCulloch C. E., Hsu C.-Y., Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization The New England Journal of Medicine 2004 351 13 1296 1370
34. Hillege H. L., Fidler V., Diercks G. F. H., Van Gilst W. H., de Zeeuw D., van Veldhuisen D. J., Gans R. O. B., Janssen W. M. T., Grobbee D. E., de Jong P. E., Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population Circulation 2002 106 14 1777 1782
35. Hostetter T. H., The chronic kidney disease predicts cardiovascular disease The New England Journal of Medicine 2004 351 13 1344 1346 (Pubitemid 39258430)
36. Klausen K., Borch-Johnsen K., Feldt-Rasmussen B., Jensen G., Clausen P., Scharling H., Appleyard M., Jensen J. S., Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes Circulation 2004 110 1 32 35 (Pubitemid 38880131)
37. Seiberlich B., Hunzelmann N., Krieg T., Weber M., Schulze-Lohoff E., Intermediate molecular weight proteinuria and albuminuria identify scleroderma patients with increased morbidity Clinical Nephrology 2008 70 2 110 117
38. Dawnay A., Wilson Mc. A. G. T., Lamb E., Kirby J. D. T., Cattell W. R., Microalbuminuria in systemic sclerosis Annals of the Rheumatic Diseases 1992 51 3 384 388
39. Koliakos G., Papachristou F., Papadopoulou M., Trachana V., Gaitatzi M., Sotiriou I., Electrophoretic analysis of urinary proteins in diabetic adolescents Journal of Clinical Laboratory Analysis 2001 15 4 178 183 (Pubitemid 32642737)
40. Francois B., Moulin G., Assenat H., Jandot B., Cahen R., The kidney in systemic scleroderma. A report of 38 consecutive cases Nephrologie 1982 3 2 85 91 (Pubitemid 12020601)
41. James M. T., Hemmelgarn B. R., Tonelli M., Early recognition and prevention of chronic kidney disease The Lancet 2010 375 9722 1296 1309
42. Gross O., Beirowski B., Koepke M.-L., Kuck J., Reiner M., Addicks K., Smyth N., Schulze-Lohoff E., Weber M., Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrom e1 Kidney International 2003 63 2 438 446 (Pubitemid 36126790)
43. Steen V. D., Medsger T. A. Jr., Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis Arthritis and Rheumatism 1998 41 9 1613 1619 (Pubitemid 28459919)
44. Penn H., Denton C. P., Diagnosis, management and prevention of scleroderma renal disease Current Opinion in Rheumatology 2008 20 6 692 696
45. Platt J. F., Rubin J. M., Ellis J. H., Lupus nephritis: predictive value of conventional and Doppler US and comparison with serologic and biopsy parameters Radiology 1997 203 1 82 86 (Pubitemid 27142711)
46. Ogata C., Kamide K., Suzuki Y., Sasaki O., Kubota Y., Sato H., Takiuchi S., Horio T., Inenaga T., Kawano Y., Evaluation of intrarenal hemodynamics by Doppler ultrasonography for renoprotective effect of angiotensin receptor blockade Clinical Nephrology 2005 64 5 352 357 (Pubitemid 41671886)
47. Rivolta R., Mascagni B., Berruti V., Di Palo F. Q., Elli A., Scorza R., Castagnone D., Renal vascular damage in systemic sclerosis patients without clinical evidence of nephropathy Arthritis and Rheumatism 1996 39 6 1030 1034 (Pubitemid 26182073)
48. Denton C. P., Lapadula G., Mouthon L., Mller-Ladner U., Renal complications and scleroderma renal crisis Rheumatology 2009 48 supplement 3 iii32 iii35
49. Scorza R., Rivolta R., Mascagni B., Berruti V., Bazzi S., Castagnone D., Di Palo F. Q., Effect of iloprost infusion on the resistance index of renal vessels of patients with systemic sclerosis Journal of Rheumatology 1997 24 10 1944 1948 (Pubitemid 27431926)
50. Air P., Rossi M., Scarsi M., Danieli E., Grottolo A., Zambruni A., Disease-modifying effects of long-term cyclic iloprost therapy in systemic sclerosis. A retrospective analysis and comparison with a control group Clinical and Experimental Rheumatology 2007 25 5 722 727 (Pubitemid 350284844)
51. Rosato E., Cianci R., Barbano B., Menghi G., Gigante A., Rossi C., Zardi E. M., Amoroso A., Pisarri S., Salsano F., N-acetylcysteine infusion reduces the resistance index of renal artery in the early stage of systemic sclerosis Acta Pharmacologica Sinica 2009 30 9 1283 1288
52. Sochman J., Peregrin J. H., Total recovery of left ventricular function after acute myocardial infarction: comprehensive therapy with streptokinase, N-acetylcysteine and percutaneous transluminal coronary angioplasty International Journal of Cardiology 1992 35 1 116 118
53. Tian N., Rose R. A., Jordan S., Dwyer T. M., Hughson M. D., Manning R. D. Jr., N-Acetylcysteine improves renal dysfunction, ameliorates kidney damage and decreases blood pressure in salt-sensitive hypertension Journal of Hypertension 2006 24 11 2263 2270 (Pubitemid 44611036)
54. Sahin G., Yalcin A. U., Akcar N., Effect of N-acetylcysteine on endothelial dysfunction in dialysis patients Blood Purification 2007 25 4 309 315 (Pubitemid 47450564)
55. Fishbane S., Durham J. H., Marzo K., Rudnick M., N-acetylcysteine in the prevention of radiocontrast-induced nephropathy Journal of the American Society of Nephrology 2004 15 2 251 260 (Pubitemid 38140765)
56. Springer T. A., Adhesion receptors of the immune system Nature 1990 346 6283 425 434
57. Denton C. P., Bickerstaff M. C. M., Shiwen X., Carulli M. T., Haskard D. O., Dubois R. M., Black C. M., Serial circulating adhesion molecule levels reflect disease severity in systemic sclerosis Rheumatology 1995 34 11 1048 1054 (Pubitemid 26013507)
58. Boehme M. W. J., Schmitt W. H., Youinou P., Stremmel W. R., Gross W. L., Clinical relevance of elevated serum thrombomodulin and soluble E-selectin in patients with Wegener's granulomatosis and other systemic vasculitides American Journal of Medicine 1996 101 4 387 394 (Pubitemid 26392856)
59. Pigott R., Dillon L. P., Hemingway I. H., Gearing A. J. H., Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells Biochemical and Biophysical Research Communications 1992 187 2 584 589
60. Stratton R. J., Coghlan J. G., Pearson J. D., Burns A., Sweny P., Abraham D. J., Black C. M., Different patterns of endothelial cell activation in renal and pulmonary vascular disease in scleroderma QJM 1998 91 8 561 566 (Pubitemid 28383234)